Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo

Blood

Volumn 106, Issue 9, 2005, Pages 3097-3104

  Siegmund, Kerstin ^b   Feuerer, Markus ^b   Siewert, Christiane ^b   Ghani, Saeed ^b   Haubold, Uta ^b   Dankof, Anja ^b   Krenn, Veit ^b   Schön, Michael P ^b   Scheffold, Alexander ^b   Lowe, John B ^b   Hamann, Alf ^b   Syrbe, Uta ^b   Huehn, Jochen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; INTERLEUKIN 2 RECEPTOR ALPHA; LIGAND; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EFFECTOR CELL; ENZYME DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 27144524938     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-05-1864     Document Type: Article

References (52)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562.
2. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-296.
3. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998;10:1969-1980.
4. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A. 2003;100:8886-8891.
5. + regulatory T cells in the steady state. J Exp Med. 2003;198:737-746.
6. + regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003;198:235-247.
7. + regulatory T cells in vivo. J Exp Med. 2003;198:249-258.
8. von Boehmer H. Dynamics of suppressor T cells: in vivo veritas. J Exp Med. 2003;198:845-849.
9. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol. 2002;169:2461-2465.
10. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med. 2003;198:259-266.
11. + regulatory T cells protects from lethal acute GVHD. Blood. 2005;105:2220-2226.
12. + immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164:183-190.
13. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 2000;30:1538-1543.
14. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215-223.
15. Woo EY, Yeh H, Chu CS, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168:4272-4276.
16. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942-949.
17. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med. 2002;195:1641-1646.
18. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med. 2005;201:1037-1044.
19. + regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502-507.
20. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol. 2002;32:1282-1291.
21. + T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol. 2000;164:240-247.
22. + Treg cells: highly potent regulators of diabetes that require TRANCERANK signals. Immunity. 2002;16:183-191.
23. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med. 2004;199:1479-1489.
24. + regulatory T cells. J Immunol. 2003;170:3939-3943.
25. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol. 1998;160:1212-1218.
26. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med. 2004;199:1455-1465.
27. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004;199:1467-1477.
28. - regulatory T cells. Proc Natl Acad Sci U S A. 2002;99:13031-13036.
29. + regulatory T cells. J Exp Med. 2004;199:303-313.
30. Schon MP, Arya A, Murphy EA, et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol. 1999;162:6641-6649.
31. + Treg and control of Leishmania major infection. J Immunol. 2005;174:5444-5455.
32. Austrup F, Rebstock S, Kilshaw PJ, Hamann A. TGF beta1-induced expression of the mucosa-related integrin alpha E on lymphocytes is not associated with mucosa-specific homing. Eur J Immunol. 1995;25:1487-1491.
33. Austrup F, Vestweber D, Borges E, et al. P- and E-selectin mediate recruitment of T helper 1 but not T helper 2 cells into inflamed tissues. Nature. 1997;385:81-83.
34. + T-cells only migrate into inflamed skin if they express ligands for E- and P-selectin. J Immunol. 1998;161:963-970.
35. Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol. 2004;4:325-335.
36. Knibbs RN, Craig RA, Natsuka S, et al. The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J Cell Biol. 1996;133:911-920.
37. Knibbs RN, Craig RA, Maly P, et al. Alpha(1,3)-fucosyltransferase VII-dependent synthesis of P-and E-selectin ligands on cultured T lymphoblasts. J Immunol. 1998;161:6305-6315.
38. Maly P, Thall A, Petryniak B, et al. The alpha(1,3) fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 1996;86:643-653.
39. + T cell migration into the skin, but normal extravasation into visceral organs. J Immunol. 2002;168:2139-2146.
40. + T cell suppressor function. Eur J Immunol. 2004;34:366-376.
41. + T cells. Arthritis Res Ther. 2005;7:R291-301.
42. + regulatory T cell function. Eur J Immunol. 2004;34:2480-2488.
43. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999;162:5317-5326.
44. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev. 1997;156:25-37.
45. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
46. Huehn J, Siegmund K, Hamann A. Migration matters: functional properties of naive- and effector/memory-like regulatory T cell subsets. Curr Top Microbiol Immunol. 2005;293:87-112.
47. Schwarz A, Maeda A, Wild MK, et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol. 2004;172:1036-1043.
48. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol. 2004;172:6539-6544.
49. + thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J Immunol. 1998;161:2620-2628.
50. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004;104:3804-3812.
51. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003;3:253-257.
52. + T cells. J Immunol. 2004;172:890-898.